GK
Georgios Kouvatseas
About Georgios Kouvatseas
Data last updated:
Georgios Kouvatseas is a Nominee Director at Veeda Clinical Research Limited (since 2025). The company operates in Pharma. Veeda Clinical Research Limited reported revenue of ₹621 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Veeda Clinical Research Limited U73100GJ2004PLC044023 | Nominee Director | 26 Mar 2025 | 2004 | ₹621 Cr (FY 2025) | Active |
Board colleagues of Georgios Kouvatseas
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Georgios Kouvatseas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Georgios Kouvatseas
Georgios Kouvatseas currently holds 1 directorship: Veeda Clinical Research Limited (Nominee Director, since 26 Mar 2025, revenue ₹621 Cr (FY 2025)).
Georgios Kouvatseas was first appointed on 26 Mar 2025 as Nominee Director at Veeda Clinical Research Limited.
The current boards of Georgios Kouvatseas's companies include Apurva Bhupendra Shah (Veeda Clinical Research Limited), Binoy Hasmukh Gardi (Veeda Clinical Research Limited), Binoy Hasmukh Gardi (Veeda Clinical Research Limited), David Paul Kenny (Veeda Clinical Research Limited), Ioannis Orfanidis (Veeda Clinical Research Limited), Jeanne Taylor Hecht (Veeda Clinical Research Limited), among others.